GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

3 Months Ended

Jan. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segment during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January 31, 2022:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2021	$	1,743	$	1,964	$	268	$	3,975
Foreign currency translation impact	(4)		(3)		(4)		(11)
Goodwill as of January 31, 2022	$	1,739	$	1,961	$	264	$	3,964

Components of other intangible assets during the period

The component parts of other intangible assets as of January 31, 2022 and October 31, 2021 are shown in the table below:

 

	Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2021
Purchased technology	$	1,742	$	972	$	770
Backlog	8		3		5
Trademark/Tradename	196		133		63
Customer relationships	357		228		129
Third-party technology and licenses	11		8		3
Total amortizable intangible assets	2,314		1,344		970
In-Process R&D	11		—		11
Total	$	2,325	$	1,344	$	981
As of January 31, 2022
Purchased technology	$	1,738	$	997	$	741
Trademark/Tradename	196		137		59
Customer relationships	355		244		111
Backlog	8		4		4
Third-party technology and licenses	11		8		3
Total amortizable intangible assets	2,308		1,390		918
In-Process R&D	11		—		11
Total	$	2,319	$	1,390	$	929

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2022	$	141
2023	$	141
2024	$	121
2025	$	96
2026	$	66
2027	$	65
Thereafter	$	288